6550-- Glucose Accu-Chek Testing Strips
Closed Special Notice Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36C25724Q0588
- Agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs (VA), VISN 17 Network Contracting Office, has issued a Special Notice announcing its intent to award a sole source contract for the procurement of Glucose Accu-Check testing strips for the Dallas VA HealthCare System Pathology and Laboratory Department. The proposed contract has a base period of June 1, 2024 to May 31, 2025, with four one-year option periods.
The purpose of this Special Notice is to inform interested parties of the government's intention to award a fixed-price contract to Roche Diabetes Care, Inc. as the sole responsible source, citing unique or highly specialized services under simplified acquisition procedures. Interested parties may submit supporting evidence by May 10, 2024 at 9:00 am CST to demonstrate their ability to fulfill the requirement, but the government retains sole discretion on whether to conduct a competitive procurement. The product service code is 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits And Sets) and the NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).
Notice text
NOTICE OF INTENT TO SOLE SOURCE
Supplies: Glucose Accu-Check Inform II test strips
THIS IS NOT A REQUEST FOR COMPETITIVE QUOTATIONS OR PROPOSALS
The Department of Veteran Affairs (VA), VISN 17 Network Contracting Office intends to award a sole source contract for the Dallas VA HealthCare System Pathology and Laboratory Department. This proposed contract action is to procure Glucose Accu-Check testing Strips for Dallas VA HealthCare System Pathology and Laboratory Department.
Base Period: 06/01/2024-05/31/2025
Option Year 1 : 06/01/2025-05/31/2026
Option Year 2: 06/01/2026-05/31/2027
Option Year 3: 06/01/2027-05/31/2028
Option Year 4: 06/01/2028-05/31/2029
Classification Code: 6550
NAICS: 325413
Government intends to award a BASE + 4 fixed-price option contract to Roche Diabetes Care, Inc, 9115 Hague Rd., Indianapolis, Indiana 46250. This acquisition is conducted under the authority of 41 U.S.C. 1901 Simplified acquisition procedures as implemented in FAR 8.405-6(a)(1)(B), only one responsible source and no other supplies or services will satisfy agency requirements.
The Contracting Officer has determined that the circumstances of the contract action deem that only one source is capable of providing the services required at the level of quality required because the services are unique or highly specialized. A determination not to compete this proposed contract is based on market research and is solely within the discretion of the government.
This Notice of Intent is not a request for competitive quotations; however, interested parties may identify their interest and capability to respond to this requirement. Any interested party that believes they can fulfill this requirement should submit supporting evidence to be reviewed. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to comply with the above requirements. This evidence shall include a letter from the Original Equipment Manufacturer (OEM) stating vendor is an authorized distributor per clause 852.212-72(c). Information must be sent to the Contracting Specialist, Teresa Arzola, Teresa.Arzola@va.gov. Responses received will be evaluated; however, a determination by the Government not to compete the proposed procurement based upon responses to this notice is solely within the discretion of the Government.
Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No cost to the government will arise as a result of contractor submissions of responses to this announcement or the government use of such information. Interested parties are responsible for adequately marking proprietary or competitively sensitive information contained in their response. No sub-contracting opportunity is anticipated. Interested parties may e-mail Teresa.Arzola@va.gov by May 10, 2024, at 9:00 am CST.
Files
| File | Type | Posted |
|---|---|---|
| 36C25724Q0588.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6550-- Glucose Accu-Chek Testing Strips | Award Notice | |
| This notice | Special Notice |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6640--advanced instruement osmopro max and glocyte consumables b+4 | Veterans Integrated Service Network 6 | No set-aside | |
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside | |
| 7A21--Siemens UniPOC Licenses and Service | VA Technology Acquisition Center | No set-aside | |
| 6505--Human Blood and Blood Products | Veterans Integrated Service Network 17 | No set-aside | |
| Q301--FY27 (BASE+4) STAT Laboratory Testing - Syracuse (VA-27-00010334) | Veterans Integrated Service Network 2 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity